Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    HAE Net Margin

    As of 2025-05-18, the Net Margin of Haemonetics Corp (HAE) is 9%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    HAE Net Margin - Historical Value
    DateValue
    2024-03-30 9%
    2023-04-01 9.9%
    2022-04-02 4.4%
    2021-04-03 9.1%
    2020-03-28 7.7%
    2019-03-30 5.7%
    2018-03-31 5%
    2017-04-01 -3%
    2016-04-02 -6.1%
    2015-03-28 1.9%
    HAE Net Margin - Peers Comparison
    TickerNameValue
    ATRIAtrion Corp11.5%
    ATRSAntares Pharma Inc25.2%
    AVNSAvanos Medical Inc-57%
    BLFSBioLife Solutions Inc-24.5%
    CERSCerus Corp-10.4%
    ICUIICU Medical Inc-4.9%
    KIDSOrthoPediatrics Corp-18.5%
    LNTHLantheus Holdings Inc20.4%
    LUNGPulmonx Corp-67.3%
    MMSIMerit Medical Systems Inc8.9%
    NEOGNeogen Corp-1%
    OSUROraSure Technologies Inc-10.5%
    OZSCOzop Energy Solutions Inc-154.8%
    QDELQuidelOrtho Corp-73.7%
    QTNTQuotient Ltd-324.9%
    RVPRetractable Technologies Inc-36%
    SDCSmileDirectClub Inc-18.4%
    SENSSenseonics Holdings Inc-349.8%
    SIBNSI-BONE Inc-18.5%
    SIENSientra Inc-81%
    SILKSilk Road Medical Inc-31.5%
    SMTISanara Medtech Inc-11.1%
    SRGASurgalign Holdings Inc-66.6%
    STAASTAAR Surgical Co-6.4%
    TELATELA Bio Inc-54.6%
    UTMDUtah Medical Products Inc33.9%
    VIVOMeridian Bioscience Inc12.7%
    XTNTXtant Medical Holdings Inc-14%
    Tickers added to watchlist